Ausgabe 2/2015
Inhalt (7 Artikel)
Can Genomic Medicine Improve Financial Sustainability of Health Systems?
Christine Y. Lu, Joshua P. Cohen
CA-SSR1 Polymorphism in Intron 1 of the EGFR Gene in Patients with Malignant Tumors Who Develop Acneiform Rash Associated with the Use of Cetuximab
Tomasz Jarząbek, Monika Rucińska, Wojciech Rogowski, Marzena Lewandowska, Jerzy Tujakowski, Maja Habib, Anna Kowalczyk, Agnieszka Byszek, Rafał Dziadziuszko, Sergiusz Nawrocki
Poorly Differentiated Neoplasms of Unknown Primary Site: Diagnostic Usefulness of a Molecular Cancer Classifier Assay
F. Anthony Greco, Wayne J. Lennington, David R. Spigel, John D. Hainsworth
Association of BAFF −871C/T Promoter Polymorphism with Hepatitis C-Related Mixed Cryoglobulinemia in a Cohort of Egyptian Patients
Mona Wagdy Ayad, Amany A. Elbanna, Dalia A. Elneily, Amany S. Sakr
Latent Tuberculosis Infection Screening in Immigrants to Low-Incidence Countries: A Meta-Analysis
Jonathon R. Campbell, Wenjia Chen, James Johnston, Victoria Cook, Kevin Elwood, Jane Krot, Fawziah Marra
Validation of an NGS Approach for Diagnostic BRCA1/BRCA2 Mutation Testing
Daniela Dacheva, Rumyana Dodova, Ivan Popov, Teodora Goranova, Atanaska Mitkova, Vanio Mitev, Radka Kaneva
A Possible Mechanistic Link Between the CYP2C19 Genotype, the Methadone Metabolite Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidene (EDDP), and Methadone-Induced Corrected QT Interval Prolongation in a Pilot Study
John F. Carlquist, David E. Moody, Stacey Knight, Eric G. Johnson, Wenfang B. Fang, John A. Huntinghouse, Jeffrey S. Rollo, Lynn R. Webster, Jeffrey L. Anderson